Document is current
Any future updates will be listed below
-
Authors
Berbel-Arcobé, Laura
Aparicio, María
Calvet, Joan
Arévalo, Marta
Nack, Annika
Juanola, Xavier
Toniolo, Elide
Maratia, Stefano
Lizán, Luis
Gratacós, Jordi https://orcid.org/0000-0003-4007-4103
-
Funding
Funding for this research was provided by:
UCB Pharma
- License Information
-
More Information
Article History
Received: 2 November 2024
Accepted: 20 December 2024
First Online: 13 January 2025
Declarations
:
: Laura Berbel-Arcobé, María Aparicio, Joan Calvet, Marta Arévalo, Annika Nack, Xavier Juanola and Jordi Gratacós declare that they have no conflicts of interest relevant to this article. Elide Toniolo and Stefano Maratia are employees of UCB Pharma. Luis Lizán is an employee of Outcomes’10 and have received payments from the sponsor for support in design and methodology, study conduct and medical writing. methodology, conduct of the study, and medical writing.
: The study was approved by the Ethics Committee for Research on medicinal products (ECRm) of Parc Taulí of Sabadell (Barcelona) (reference 2022/5001) and conducted in accordance with the Declaration of Helsinki, following the standards of Good Clinical Practice. All ethics committees of the participating centers provided their approval for this study.
